These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31392570)

  • 1. Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis.
    Kamal N; Koh C; Samala N; Fontana RJ; Stolz A; Durazo F; Hayashi PH; Phillips E; Wang T; Hoofnagle JH;
    Hepatol Int; 2019 Sep; 13(5):641-648. PubMed ID: 31392570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levocarnitine and vitamin B complex for the treatment of pegaspargase-induced hepatotoxicity: A case report and review of the literature.
    Blackman A; Boutin A; Shimanovsky A; Baker WJ; Forcello N
    J Oncol Pharm Pract; 2018 Jul; 24(5):393-397. PubMed ID: 28523950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pegaspargase: a review of clinical studies.
    Graham ML
    Adv Drug Deliv Rev; 2003 Sep; 55(10):1293-302. PubMed ID: 14499708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levocarnitine for pegaspargase-induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia.
    Schulte R; Hinson A; Huynh V; Breese EH; Pierro J; Rotz S; Mixon BA; McNeer JL; Burke MJ; Orgel E
    Cancer Med; 2021 Nov; 10(21):7551-7560. PubMed ID: 34528411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desensitization to pegaspargase in children with acute lymphoblastic leukemia and lymphoblastic lymphoma.
    August KJ; Farooki S; Fulbright JM; August A; Portnoy JM; Pommert L; Burke MJ; Guest EM
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28021. PubMed ID: 31571395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).
    Dinndorf PA; Gootenberg J; Cohen MH; Keegan P; Pazdur R
    Oncologist; 2007 Aug; 12(8):991-8. PubMed ID: 17766659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial.
    Patel B; Kirkwood AA; Dey A; Marks DI; McMillan AK; Menne TF; Micklewright L; Patrick P; Purnell S; Rowntree CJ; Smith P; Fielding AK
    Leukemia; 2017 Jan; 31(1):58-64. PubMed ID: 27480385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEGging down risk factors for peg-asparaginase hepatotoxicity in patients with acute lymphoblastic leukemia
    Rausch CR; Marini BL; Benitez LL; Elias A; Burke PW; Bixby D; Perissinotti AJ
    Leuk Lymphoma; 2018 Mar; 59(3):617-624. PubMed ID: 28718698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance.
    Horvat TZ; Pecoraro JJ; Daley RJ; Buie LW; King AC; Rampal RK; Tallman MS; Park JH; Douer D
    Leuk Res; 2016 Nov; 50():17-20. PubMed ID: 27631159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma asparaginase activity and asparagine depletion in acute lymphoblastic leukemia patients treated with pegaspargase on Children's Oncology Group AALL07P4
    Schore RJ; Devidas M; Bleyer A; Reaman GH; Winick N; Loh ML; Raetz EA; Carroll WL; Hunger SP; Angiolillo AL
    Leuk Lymphoma; 2019 Jul; 60(7):1740-1748. PubMed ID: 30626253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological features of L-asparaginase-induced liver disease.
    Sahoo S; Hart J
    Semin Liver Dis; 2003 Aug; 23(3):295-9. PubMed ID: 14523682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia.
    Hawkins DS; Park JR; Thomson BG; Felgenhauer JL; Holcenberg JS; Panosyan EH; Avramis VI
    Clin Cancer Res; 2004 Aug; 10(16):5335-41. PubMed ID: 15328169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levocarnitine for pegasparaginase-induced hepatotoxicity in acute lymphoblastic leukemia.
    Trang E; Ngo D; Chen J; Aldoss I; Salhotra A; Pullarkat V
    Leuk Lymphoma; 2020 Dec; 61(13):3161-3164. PubMed ID: 32787645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of asparaginase activity levels following treatment with pegaspargase.
    Bleyer A; Asselin BL; Koontz SE; Hunger SP
    Pediatr Blood Cancer; 2015 Jun; 62(6):1102-5. PubMed ID: 25393506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacoeconomic analysis of pegaspargase versus native Escherichia coli L-asparaginase for the treatment of children with standard-risk, acute lymphoblastic leukemia: the Children's Cancer Group study (CCG-1962).
    Kurre HA; Ettinger AG; Veenstra DL; Gaynon PS; Franklin J; Sencer SF; Reaman GH; Lange BJ; Holcenberg JS
    J Pediatr Hematol Oncol; 2002; 24(3):175-81. PubMed ID: 11990302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pegaspargase-induced hypertriglyceridemia in a patient with acute lymphoblastic leukemia.
    Lau KM; Saunders IM; Goodman A
    J Oncol Pharm Pract; 2020 Jan; 26(1):193-199. PubMed ID: 30823860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic alternatives to native L-asparaginase in the treatment of adult acute lymphoblastic leukemia].
    Thomas X; Cannas G; Chelghoum Y; Gougounon A
    Bull Cancer; 2010 Sep; 97(9):1105-17. PubMed ID: 20693115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amoxicillin-Clavulanate-Induced Liver Injury.
    deLemos AS; Ghabril M; Rockey DC; Gu J; Barnhart HX; Fontana RJ; Kleiner DE; Bonkovsky HL;
    Dig Dis Sci; 2016 Aug; 61(8):2406-2416. PubMed ID: 27003146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pegaspargase: A Review in Acute Lymphoblastic Leukaemia.
    Heo YA; Syed YY; Keam SJ
    Drugs; 2019 May; 79(7):767-777. PubMed ID: 31030380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The eukaryotic initiation factor 2 kinase GCN2 protects against hepatotoxicity during asparaginase treatment.
    Wilson GJ; Bunpo P; Cundiff JK; Wek RC; Anthony TG
    Am J Physiol Endocrinol Metab; 2013 Nov; 305(9):E1124-33. PubMed ID: 24002574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.